A three-year, $1.6 million grant to identify patients at risk for a serious secondary neurological complication that can arise after subarachnoid hemorrhage (SAH) has been awarded to UTHealth Houston ...

Egret Therapeutics, a portfolio company of Turret Capital Management LP, has announced FDA clearance of its IND application for EGT-101 for the treatment of delayed cerebral ischemia following ...

Clazosentan failed to meet the primary endpoint of preventing clinical deterioration as a result of delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH), ...

Among adults with a certain type of bleeding stroke, those who used marijuana within the last 3-30 days were more than twice as likely to develop a serious stroke complication that increases the risk ...

Blood transfusions are commonly given to patients with acute brain injury, but there is ongoing debate over whether a restrictive or liberal transfusion strategy is preferable. Results of the TRICC ...

A research team led by Professor Shen Jiangang from the School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) reveals that Angong Niuhuang Wan (AGNHW), a classical ...